Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
BCYC
#3484
Bicycle Therapeutics plc American Depositary Shares
5.0
6
USD
+1.61%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+1.61%
Changement Mensuel
+4.98%
Evolution sur 6 mois
-35.95%
Changement Annuel
-30.49%
Clôture Précédente
4.9
8
Open
5.0
6
Bid
Ask
Low
5.0
6
High
5.0
6
Volume
42
Marchés
Actions des Marchés US
Soins de Santé
BCYC
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
23.09 M
29.6 M
30.02 M
37.88 M
47.71 M
50.27 M
—
Valuation ratios
Enterprise value
429.4 M
1.4 B
605.8 M
217.05 M
-171.56 M
-272.2 M
-1.3 B
Price to earnings ratio
—
-22.8
-7.89
-3.63
-4.83
-2.24
-9.02
Price to sales ratio
—
130.42
61.52
24.33
23.1
6.76
69.17
Price to cash flow ratio
—
-103.12
-10.33
-10.83
-4.95
-1.96
-9.46
Price to book ratio
—
4.41
3.29
1.77
1.03
0.8
1.3
Enterprise value to EBITDA ratio
-8.18
-21.23
-4.97
-0.98
1
1.11
2.5
Profitability ratios
Return on assets %
-0.32
-0.14
-0.27
-0.3
-0.18
-0.31
-0.27
Return on equity %
-0.53
-0.19
-0.42
-0.49
-0.21
-0.36
-0.33
Return on invested capital %
-163.78
-271.48
-901.36
-1 275.56
-1 685.04
-2 598.15
-2 105.36
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-500.1
-560.98
-806.56
-704.13
-594.96
-340.38
-4 279.65
EBITDA margin %
-487.81
-548.94
-781.06
-679.86
-574.62
-331.53
-4 187.43
Net margin %
-490.95
-571.25
-779.35
-669.72
-479.18
-301.66
-3 858.47
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
6.73
12.65
6.92
8.08
13.81
11.98
47.89
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.08
0.04
0.03
0.05
0.05
0.09
0.09
Solvency ratios
Debt to assets ratio
0.09
0.09
0.11
0.08
0.04
—
—
Debt to equity ratio
0.16
0.12
0.16
0.12
0.05
—
—
Long term debt to total assets ratio
0.09
0.06
0.07
0.05
0.03
—
—
Long term debt to total equity ratio
0.15
0.09
0.11
0.08
0.04
—
—
Per share metrics
Operating cash flow per share
—
-0.59
-2.9
-1.7
-2.83
-3.6
-3.61
EBIT per share
—
-2.62
-3.93
-5.34
-3.61
-3.57
-3.57
EBITDA per share
—
-2.56
-3.81
-5.15
-3.48
-3.47
-3.47
Total debt per share
—
1.67
1.49
1.26
0.69
—
—
Cash per share
—
17.5
11.43
14.79
15.11
9.07
40.3
Net current asset value per share
—
18.3
12.45
15.79
15.95
9.86
44.5
Tangible book value per share
—
13.82
9.13
10.42
13.62
8.8
38.09
Working capital per share
—
16.85
10.66
13.83
14.8
9.03
40.73
Book value per share
—
13.82
9.13
10.42
13.62
8.8
38.09
Nouvelles
RBC Capital abaisse l’objectif de cours de Bicycle Therapeutics à 7$
Needham réduit l’objectif de cours de Bicycle Therapeutics suite au retard d’essai
Citizens réduit l’objectif de cours de Bicycle Therapeutics suite à un changement stratégique
Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)
Truist réduit l’objectif de cours de Bicycle Therapeutics suite à un changement de stratégie
Morgan Stanley reiterates Bicycle Therapeutics stock rating on program shift
Le BPA de Bicycle Therapeutics a dépassé les attentes de 0,65$, le CA a surpassé les prévisions
Bicycle Therapeutics earnings beat by $0.65, revenue topped estimates
Seres names Richard Kender as executive chair and interim CEO
Bicycle Therapeutics annonce des changements de direction pour sa prochaine phase
Bicycle Therapeutics announces leadership changes for next phase
Oppenheimer reiterates Outperform rating on Bicycle Therapeutics stock